Drug Search Results
More Filters [+]

Trovafloxacin

Alternative Names: trovafloxacin, trovan
Latest Update: 2007-10-23
Latest Update Note: Clinical Trial Update

Product Description

Mechanisms of Action: TOP2 Inhibitor

Novel Mechanism: No

Modality: Small Molecule

Route of Administration: Intravenous,Oral

FDA Designation: None *

Approval Status: Approved

Approved Countries: Canada | Chile | Colombia | European Medicines Agency | Germany | Greece | Ireland | New Zealand | Peru | Portugal | Spain | Venezuela

Approved Indications: None

Known Adverse Events: None

Company: None
Company Location:
Company CEO:
Additonal Commercial Interests: None

Clinical Description

Map of Global Clinical Trials for Trovafloxacin

Countries in Clinic:

Active Clinical Trial Count:

Highest Development Phases

Trial

Phase

Trial Status

Disease

Primary Completion Date

Probability of Success

Recent News Events

Date

Type

Title